Recombinant Human TP53I3 Protein，His

TP53I3, also known as the Tumor Protein p53 Inducible Protein 3, is a gene that has garnered significant interest in cancer research due to its role in the cellular response to stress and its association with the tumor suppressor protein p53. The protein encoded by TP53I3 is involved in various biological processes, including apoptosis, cell cycle regulation, and the response to DNA damage, which positions it as a critical player in maintaining genomic integrity. Research has shown that TP53I3 is upregulated in response to p53 activation, suggesting its potential role as a mediator of the p53 pathway. Alterations in TP53I3 expression have been linked to various types of cancers, making it a candidate for further exploration in cancer diagnostics and therapeutics. Additionally, studies have suggested that TP53I3 may influence cellular metabolism and oxidative stress responses, contributing to tumor progression and therapies' efficacy. Given the pivotal role of p53 in cancer biology, understanding TP53I3's function and mechanism can provide insights into tumorigenesis and highlight its potential as a biomarker or therapeutic target in cancer management. Continued investigations into the TP53I3 protein could yield valuable information for developing novel strategies in cancer treatment, particularly in tumors exhibiting p53 dysfunction. The evolving research surrounding TP53I3 underscores its importance in the broader context of oncogenic processes and underscores the need for further studies to elucidate its precise role in cancer biology.